Felbamate: a clinical trial for complex partial seizures
- PMID: 2044501
- DOI: 10.1111/j.1528-1157.1991.tb04668.x
Felbamate: a clinical trial for complex partial seizures
Abstract
We performed a randomized, double-blind, three-period cross-over study of felbamate (FBM, 2-phenyl-1,3-propanediol dicarbamate: Carter-Wallace 554) in patients with complex partial seizures. Patients continued carbamazepine (CBZ) throughout the study and were observed in the hospital for the entire trial period. The entry criteria required at least six seizures in a 3-week baseline period (and no more than 1 week with a single seizure) with CBZ alone. Thirty subjects were randomized. Two left the study after randomization, 1 owing to seizure exacerbation, and 1 owing to hyponatremia, which may have been related to CBZ therapy. The daily dosage of 50 mg/kg (maximum 3,000 mg) FBM per day was well tolerated by all 28 patients who completed the study. Only mild adverse experience were observed during the trial. FBM reduced CBZ level (p less than 0.0001; 95% confidence interval -28%, -20%). There was no significant difference in seizure frequency between placebo and FBM periods (one-sided p = 0.172), but when a correction was made for the lower CBZ level noted during FBM periods, the data suggested a strong antiseizure effect of FBM.
Similar articles
-
Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.Epilepsia. 1991 May-Jun;32(3):398-406. doi: 10.1111/j.1528-1157.1991.tb04669.x. Epilepsia. 1991. PMID: 1904346 Clinical Trial.
-
Felbamate for partial seizures: results of a controlled clinical trial.Neurology. 1991 Nov;41(11):1785-9. doi: 10.1212/wnl.41.11.1785. Neurology. 1991. PMID: 1944909 Clinical Trial.
-
Felbamate monotherapy: implications for antiepileptic drug development.Epilepsia. 1995 Nov;36(11):1105-10. doi: 10.1111/j.1528-1157.1995.tb00468.x. Epilepsia. 1995. PMID: 7588454 Clinical Trial.
-
Felbamate in the treatment of partial-onset seizures.Epilepsia. 1994;35 Suppl 5:S58-61. doi: 10.1111/j.1528-1157.1994.tb05970.x. Epilepsia. 1994. PMID: 8039474 Review.
-
Felbamate: successful development of a new compound for the treatment of epilepsy.Epilepsia. 1993;34 Suppl 7:S30-3. doi: 10.1111/j.1528-1157.1993.tb04592.x. Epilepsia. 1993. PMID: 8243376 Review.
Cited by
-
Chemical analysis of the Chinese liquor Luzhoulaojiao by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry.Sci Rep. 2015 Apr 10;5:9553. doi: 10.1038/srep09553. Sci Rep. 2015. PMID: 25857434 Free PMC article.
-
Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat.Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):173-8. doi: 10.1007/BF00178717. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8857594
-
Placebos in clinical practice and research.J Med Ethics. 1996 Jun;22(3):140-6. doi: 10.1136/jme.22.3.140. J Med Ethics. 1996. PMID: 8798935 Free PMC article. Review.
-
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.Clin Pharmacokinet. 1997 Sep;33(3):214-24. doi: 10.2165/00003088-199733030-00004. Clin Pharmacokinet. 1997. PMID: 9314612 Review.
-
Choice and use of newer anticonvulsant drugs in older patients.Drugs Aging. 2000 Dec;17(6):441-52. doi: 10.2165/00002512-200017060-00002. Drugs Aging. 2000. PMID: 11200305 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources